LSTM Home > LSTM Research > LSTM Online Archive

Use and reliability of multiplex bead-based assays (Luminex) at Containment Level 4.

Downloads

Downloads per month over past year

Dowall, Stuart D, Graham, Victoria A, Fletcher, Tom E. and Hewson, Roger (2019) 'Use and reliability of multiplex bead-based assays (Luminex) at Containment Level 4.'. Methods, Vol 158, pp. 17-21. (In Press)

[img] Text
Tom Fletcher - Luminex 25 02 19.DOCX - Submitted Version
Restricted to Repository staff only until 13 February 2020.
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (945kB)
[img] Text
1-s2.0-S1046202318301725-main.pdf - Accepted Version
Restricted to Repository staff only until 13 January 2020.
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (704kB)

Abstract

In the UK, research on hazard group 4 (HG4) pathogens requires specialised Containment Level 4 (CL4) facilities. These differ from Biosafety Level 4 (BSL4) conditions in that work is conducted in class III microbiological safety cabinets for primary containment instead of using positive pressure suits. This presents unique challenges associated with the physical restrictions of working in a limited space, and prohibits the use of many techniques and specialist equipment. In consequence, detailed studies on the biology of HG4 pathogens and in particular their immunological relationships with the host are understudied in the UK; for example, the majority of immunological assays with which the immune system is interrogated require specialist equipment that is unsuitable for CL4.
Multiplexing to simultaneously measure multiple analytes is increasingly being used in immunological studies. This assay is attractive for CL4 work because it reduces the time spent in the laboratory whilst maximising the use of valuable sample volume. The Luminex microsphere approach allows for the determination of many cytokines and chemokines, however, the detection system uses fixed aligned lasers and integrated computer systems which are unsuitable for use at CL4. Therefore, we have developed an approach in which the Luminex assay is conducted within the CL4 laboratory and a formalin-fixation stage is introduced to allow for analysis to be undertaken outside of containment. Quality control preparations allow the assay characteristics to be monitored and analysis of assay performance to be evaluated. Our data demonstrate that Luminex is an applicable tool for use at CL4 and that assays can be run reliably to generate reproducible standardised data across different plates and individual experiments.

Item Type: Article
Subjects: QV Pharmacology > Drug Standardization. Pharmacognosy. Medicinal Plants > QV 771 Standardization and evaluation of drugs
QW Microbiology and Immunology > Immunity by Type > QW 568 Cellular immunity. Immunologic cytotoxicity. Immunocompetence. Immunologic factors (General)
WA Public Health > Preventive Medicine > WA 243 Diagnositic services
WA Public Health > Accident and Injury Prevention. Disasters > WA 250 General works
Faculty: Department: Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI): https://doi.org/10.1016/j.ymeth.2019.02.008
Depositing User: Stacy Murtagh
Date Deposited: 26 Feb 2019 16:52
Last Modified: 12 Apr 2019 14:01
URI: http://archive.lstmed.ac.uk/id/eprint/10231

Statistics

View details

Actions (login required)

Edit Item Edit Item